Morie A. Gertz, MD of Mayo Clinic discusses the new novel agents which might have significant therapeutic impact in multiple myeloma at the Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content